Effect of iron chelators on proliferatio
✍
Anthony Kicic; Anita C. G. Chua; Erica Baker
📂
Article
📅
2001
🏛
John Wiley and Sons
🌐
English
⚖ 382 KB
👁 1 views
## BACKGROUND. The siderophore desferrioxamine mesylate (DFO) is used routinely in clinical practice to treat diseases of iron (Fe) overload. Recent studies suggest that DFO and other chelators may have potential in the treatment of cancer. The current study reports the findings obtained when a nu